22 November 2024

Tag: psychedelics

Pure Extracts Technologies (PULL.C) enlists Cannavolve to widen their distribution reach

Pure Extracts Technologies (PULL.C) subsidiary Pure Extracts Manufacturing pulled in an agreement with adult recreational cannabis retail sales agency, Cannavolve, today, according to a press release. Cannavolve offers a cannabis sales solution and will take care of sales in the field, including in-store product training for Pure Pulls Vapes and Pure Chews. “With approximately 2,000…

7 May 2021
Revive Therapeutics (RVV.C) files for FDA Orphan Drug Designation for psilocybin in traumatic brain injury

“Psilocybin offers a potential solution to manage moderate to severe cases of TBI,” stated RVV, “Psilocybin has the potential with its neuroreparative effect to improve loss of cognitive function after TBI lessening disability”.

28 April 2021
Core One Labs (COOL.C) takes their artificial psilocybin research to UBC

Core One Labs (COOL.C) subsidiary, Vocan Biotechnologies, and the University of British Columbia (UBC), came to terms on a collaborative research agreement today, according to a press release. The collaboration gives Vocan access to a well-funded, world-class research facility and team to enhance their position in the nascent psychedelic medicine space, especially given the increasing…

27 April 2021
Delic Holdings (DELC.C) gives Q1, 2021 update on its psychedelic business divisions

On February 5th, 2021 DELIC announced the acquisition of KIC, who over the last 3 years have overseen 4,000 ketamine infusion treatments, while revenues increase to over USD $1.5 million.

13 April 2021
Pure Extracts (PULL.C) to enter U.S. market through JV in Michigan

If the LOI becomes a binding contract, Pure Extracts will contribute “a mix of equipment and cash to the venture”, which will allow the partners to rapidly scale-up to meet the rising demand for recreation cannabis concentrates and edibles throughout Michigan.

9 April 2021
Pure Extracts (PULL.C) looks to level up with dealers license application

At a time when many cannabis companies are enjoying bursts of investor interest, management at BC-based extractor Pure Extracts (PULL.C) must be getting frustrated as they roll out new contracts, new manufacturing lines, and advance in their pursuit of licensing that would allow them to break out into psychedelics. In essence, they’re hitting all the…

5 March 2021
Delic Holdings (DELC.C) acquires licensed psilocybin/cannabis lab, is doing legal shroom business

For a year, naysayers have dismissed the early stage shroom boom as being a pumpy bunch of pubco RTOs that won’t be able to do business legally for years. To be fair, there’s some basis to that dismissal. But only some. We’ve also been talking about how Delic Holdings (DELC.C) was an all-star team of…

26 February 2021
Pure Extracts (PULL.C) submits 20 SKUs to Health Canada, based on its proprietary CO2 extraction technology

PULL submitted over 20 Stock Keeping Units (SKU) product identifiers for approval including THC vapes, CBD vapes, 1:1 blended vapes, and 3 different flavours/formulations of gummies.

25 February 2021
Pure Extracts (PULL.C) cuts a licensing deal with Taste-T, the maker of Fireball Cannabis Gummies

Included in the agreement is the delivery to Pure Extracts’ British Columbia facility of one of Taste-T’s custom built gummie-manufacturing machines, certified to Canadian standards.

16 February 2021
Canntab (PILL.C) yeets another patent for hard-pressed, long release cannabis pills

I’ve made no secret of the fact that the Canadian cannabis market frequently annoys the hell out of me. What I want is for it to be a mature space that more and more adults are making use of, and that is free to innovate, free to be excellent, free to market itself properly, and…

5 February 2021